Research

NeuroSGC created to increase volume and quality of cell assays for drug discovery

A new partnership between the Structural Genomics Consortium (SGC) and the Montreal Neurological Institute and Hospital (The Neuro) will use a unique open science framework to help scientists discover new targets for drug development for neurological diseases.

The partnership, called NeuroSGC, will initially focus on Parkinson’s disease and amyotrophic lateral sclerosis (ALS), two of the most common neurodegenerative diseases.

Classified as: open science, MNI
Published on: 6 Dec 2017

Industry and academia team up for the benefit of people suffering from ALS

A unique industry-academia partnership will increase the rate at which promising drug compounds can be tested as potential treatments for amyotrophic lateral sclerosis (ALS), a disease with no known cure that affects 200,000 people worldwide.

The partnership between The Montreal Neurological Institute and Hospital (MNI) and Takeda Pharmaceutical Company Limited (Takeda) will allow compounds developed by Takeda scientists to be tested on cell lines produced at the MNI.

Classified as: Takeda, stem cells, ALS, hiPSCs, amyotrophic lateral sclerosis, open science, C-BIGR, Open Drug Discovery Platform
Published on: 4 Dec 2017

Senate of Canada recognizes outstanding contributions to the community 

The Senate of Canada has awarded Alan Evans a Canada 150 medal for his commitment to advancements in Alzheimer’s disease and palliative care research. He was nominated by Senator Judith Seidman, a former research fellow at the Montreal Neurological Institute and Hospital, and Associate Professor of the McGill School of Social Work.

Classified as: Alan Evans
Category:
Published on: 27 Nov 2017

Grants for Heather Durham, Stefano Stifani and Jay Ross total just over $2 million 

Three MNI researchers have received grants from the ALS Society of Canada worth a total of more than $2 million.  

Published on: 24 Nov 2017

Brain stimulation can change how much we enjoy and value music

Enjoyment of music is considered a subjective experience; what one person finds gratifying, another may find irritating. Music theorists have long emphasized that although musical taste is relative, our enjoyment of music, be it classical or heavy metal, arises, among other aspects, from structural features of music, such as chord or rhythm patterns that generate anticipation and expectancy.

Classified as: music, Robert Zatorre, Ernest Mas Herrero, fronto-striatal circuits, TMS, transcranial magnetic stimulation
Published on: 20 Nov 2017

Dr Susan Kahn was interviewed for the September issue of  Le Specialiste!

Les grands noms de la médecine au Québec!

Read the article here.  See page 17!

Category:
Published on: 9 Nov 2017

The Azrieli Centre for Autism Research will foster innovations in therapy and a better understanding of Autism Spectrum Disorder.

A new research centre in Montreal will help lift the shroud of mystery surrounding autism spectrum disorder (ASD), and lead to the development of better diagnostic tools and more effective therapies for people with autism.

Classified as: Autism Research, Azrieli Foundation, autism
Published on: 23 Oct 2017

A Brilliant Night has donated a total of $1.6 million since 2015

A night dedicated to the memory of those lost to brain cancer and in honour of those still fighting the disease will raise money for research that will lead to better treatments.

Classified as: a brilliant night, Kevin Petrecca, brain cancer, brain tumour
Published on: 10 Oct 2017

Research shows how the brain’s motor signals sharpen our ability to decipher complex sound flows

Whether it is dancing or just tapping one foot to the beat, we all experience how auditory signals like music can induce movement. Now new research suggests that motor signals in the brain actually sharpen sound perception, and this effect is increased when we move in rhythm with the sound.

Classified as: Motor signals, Sound perception, Benjamin Morillon, Sylvain Baillet
Published on: 5 Oct 2017

Research symposium, public education event and ALS walk planned

Multiple events planned for this week will help educate the public about amyotrophic lateral sclerosis (ALS), a devastating disease that still has no cure.

Classified as: ALS research, ALS, ALS awareness, Research symposium, ALS walk, Neuro, Dr. Angela Genge, ALS Society of Quebec
Published on: 13 Sep 2017

Society recognizes scholarly, research and artistic excellence.

Congratulations to Dr. Edith Hamel and Dr. Robert Zatorre, who have been elected Fellows of the Royal Society of Canada. Election to the academies of the Royal Society of Canada is the highest honour a scholar can achieve in the Arts, Humanities and Sciences.

Classified as: edith hamel, Robert Zatorre, royal society of canada, rsc
Published on: 7 Sep 2017

The Neuro to launch open research publishing platform with F1000

A new partnership between The Neuro and F1000 will create a publishing platform for researchers that will speed the progress of neuroscience discovery.

The Montreal Neurological Institute and Hospital of McGill University (The Neuro) is partnering with F1000, a provider of support services for researchers, institutes and funders, to create a new open research publishing platform called MNI Open Research (https://mniopenresearch.org).

Classified as: F1000, Research, open science, Publishing
Published on: 30 Aug 2017

Abnormalities shown to first appear in brain networks involved in sensory processing

The origins of autism remain mysterious. What areas of the brain are involved, and when do the first signs appear? New findings published in Biological Psychiatry brings us closer to understanding the pathology of autism, and the point at which it begins to take shape in the human brain. Such knowledge will allow earlier interventions in the future and better outcomes for autistic children.

Classified as: autism, IBIS, Alan Evans, John Lewis, Ludmer Centre, ASD
Published on: 29 Aug 2017

For people suffering from depression, a day without treatment can seem like a lifetime. A new study explains why the most commonly prescribed antidepressants can take as long as six weeks to have an effect. The findings could one day lead to more effective and faster acting drugs.

Classified as: Antidepressants, depression, SSRIs, selective serotonin reuptake inhibitors, cholecystokinin cells, CCK, hippocampus, Adrien Peyrache, Paul Greengard, Rockefeller University, McGill University
Published on: 3 Aug 2017

Researchers train brains to use different regions for same task

Practice might not always make perfect, but it’s essential for learning a sport or a musical instrument. It's also the basis of brain training, an approach that holds potential as a non-invasive therapy to overcome disabilities caused by neurological disease or trauma.

Research at the Montreal Neurological Institute and Hospital of McGill University (The Neuro) has shown just how adaptive the brain can be, knowledge that could one day be applied to recovery from conditions such as stroke.

Classified as: brain research, brain plasticity, Dave Liu, Christopher Pack, area MT
Published on: 19 Jul 2017

Pages